Quarterly report [Sections 13 or 15(d)]

Equity Compensation

v3.25.1
Equity Compensation
3 Months Ended
Mar. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Equity Compensation

Note 12 – Equity Compensation

Equity classified restricted stock units The following table summarizes aggregate activity for RSUs for the three months ended March 31, 2025:

 

 

 

Shares

 

 

Weighted Average
Grant Date Fair
Value per Share

 

Outstanding at December 31, 2024

 

 

2,137

 

 

$

14.38

 

Issued

 

 

255

 

 

$

15.24

 

Vested

 

 

(197

)

 

$

20.09

 

Forfeited, expired, or canceled

 

 

(129

)

 

$

17.39

 

Outstanding at March 31, 2025

 

 

2,066

 

 

$

13.66

 

RSUs are valued at the Company’s closing stock price on the date of grant and generally vest over a one- to four-year period. Compensation expense for RSUs is recognized on a straight-line basis.

The Company grants performance-based RSUs, which are included in the RSUs described above, to executive officers and other key employees that vests upon the achievement of specified market or internal performance goals. The performance-based RSUs are recognized as expense on a straight-line basis over the vesting period which is typically three to four years. Management performs a regular assessment to determine the likelihood of meeting the related metrics and adjusts the expense recognized if necessary. During the three months ended March 31, 2025, 13 performance-based RSUs were earned and issued and 37 performance based RSUs were forfeited. The Company did not grant any performance-based RSUs during the three months ended March 31, 2025.

Stock-based compensation expense Aggregate stock-based compensation expense recognized in the condensed consolidated statements of operations was as follows:

 

 

 

Three months ended March 31,

 

 

 

2025

 

 

2024

 

Selling, general and administrative

 

$

3,281

 

 

$

3,942

 

Total stock-based compensation expense, before tax

 

 

3,281

 

 

 

3,942

 

Income tax benefit

 

 

109

 

 

 

136

 

Total stock-based compensation expense, after tax

 

$

3,172

 

 

$

3,806

 

Income tax benefit relates to vested RSUs. Due to the Company's full valuation allowance on its net deferred tax assets, there is no income tax benefit on the unvested RSUs. At March 31, 2025, the Company had $21,000 of total unamortized compensation expense related to non-vested RSUs. That cost is expected to be recognized over a weighted-average period of 2.11 years.